Clinical Trials
The following is a list of clinical trials with which the Department of Neurology at Dartmouth-Hitchcock Medical Center is currently involved. Talk to your doctor to find out if a clinical trial is right for you.
General Neurology Clinical Trials
EEG-MRI Localization of Brain Pathology and Function in Epilepsy
General Neurology
D07005
Jobst
Mental Health and Quality of Life to Improve Outcomes in Epilepsy
General Neurology
D11285
Caller
Multiple Sclerosis Clinical Trials
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy of Natalizumab on Reducing Disability Progression in Subjects With Secondary Progressive Multiple Sclerosis
Multiple Sclerosis
F12199
Pachner
Brain Plasticity/Repair Genes and Neuroimaging in MS
Multiple Sclerosis
FED10086
Wishart
Long-term, prospective, observational, multinational,parallel-cohort study monitoring safety in patients with MS newly started with fingolimod once daily or treated with another approved disease-modifying therapy
Multiple Sclerosis
F12059
Pachner
Cerebrovascular Disease and Stroke Clinical Trials
A Randomised, Double-Blind, Parallel-Group Placebo-Controlled Phase III Study to Evaluate the Efficacy and Safety of Desmoteplase in Subjects With Acute Ischemic Stroke
Cerebrovascular Disease and Stroke
F11108
Lukovits
Insulin Resistance Intervention after Stroke (IRIS) Trial
Cerebrovascular Disease and Stroke
D05002
Lukovits
Investigation Into The Frequency Of Apnea In The Setting Of Acute Intracerebral Hemorrhage (I-ACES Trial)
Cerebrovascular Disease and Stroke
D12162
Guardia
Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trial, a Randomized, Double-Blind, Multicenter Clinical Trial
Cerebrovascular Disease and Stroke
SF11218
Lukovits
Epilepsy Clinical Trials
A Prospective, Open-Label Study of the Structure and Function of the Retina in Adult Patients with Refractory Complex Partial Seizures Treated with Vigabatrin (Sabril)
Epilepsy
F11047
Jobst
A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Parallel-Group Study to Evaluate the Efficacy and Safety of Brivaracetam in Subjects (≥16 to 80 Years Old) with Partial Onset Seizures
Epilepsy
F11025
Holmes
HOBSCOTCH: HOme Based Self-management and COgnitive Training CHanges Lives
Epilepsy
D12217
Jobst
Tuberous Sclerosis Complex Natural History Study: Renal Manifestations
Epilepsy
D08004
Holmes
Movement Disorders Clinical Trials
A Multicenter, Double-Blind, Placebo-Controlled Phase II Study of Pioglitazone in Early Parkinson's Disease
Movement Disorders
FED11031
Lee
Neuromuscular Clinical Trials
A Phase IIb, Multi-National, Double-Blind, Randomized, Placebo-Controlled Study To Evaluate The Safety, Tolerability, And Efficacy Of CK-2017357 In Patients With Amyotrophic Lateral Sclerosis (ALS)
Neuromuscular
F12143
Cohen
Controlled Trial of 3,4 Diaminopyridine in Lambert-Eaton Myasthenic Syndrome (LEMS)
Neuromuscular
D04013
Cohen
Epidemiology of Amyotrophic Lateral Sclerosis in the Upper Valley and Northern New England
Neuromuscular
D06019
Stommel
